Filing Details
- Accession Number:
- 0001562180-22-006118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-16 16:53:31
- Reporting Period:
- 2022-08-12
- Accepted Time:
- 2022-08-16 16:53:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1503274 | Quanterix Corp | QTRX | Laboratory Analytical Instruments (3826) | 208957988 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1867276 | Masoud Toloue | C/O Quanterix Corporation 900 Middlesex Turnpike Billercia MA 01821 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-12 | 105,000 | $10.43 | 185,823 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchase of shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with Dr. Toloue's sale of 5,564 shares on June 13, 2022, 432 shares on July 5, 2022 and 446 shares on August 1, 2022, each of which was made to cover taxes upon the vesting of RSUs. Dr. Toloue has agreed to pay Quanterix Corporation $33,350.20, representing the full amount of the profit realized in connection with the short-swing transaction.
- This transaction was executed in multiple trades at prices ranging from $10.1101 to $10.50. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 67,548 restricted stock units.